Novel oncolytic adenoviral vectors

Details for Australian Patent Application No. 2002247188 (hide)

Owner NOVARTIS PHARMA AG

Inventors Hay, Carl M.; Xie, Yuefeng; Stewart, David A.; Ennist, David Leonard; Jakubczak, John Leonard; Clarke, Lori; Gorziglia, Mario; Kaleko, Michael; Ryan, Patricia, Clara; Hallenbeck, Paul L.; Phipps, Sandrina; Police, Sehidhar Reddy; Connelly, Sheila; Forry-Schaudies, Suzanne; Cheng, Cheng

Agent Davies Collison Cave

Pub. Number AU-A-2002247188

PCT Pub. Number WO2002/067861

Priority 60/295,037 01.06.01 US; 60/348,670 14.01.02 US; 60/270,922 23.02.01 US

Filing date 22 February 2002

Wipo publication date 12 September 2002

Event Publications

6 March 2003 Application Open to Public Inspection

  Published as AU-A-2002247188

19 October 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002247189-70 HUMAN SECRETED PROTEINS

2002247187-Transit best fare system and method